LINC02174: A Long Intergenic Non-Protein-Coding RNA (G105377536)

Target Name: LINC02174

NCBI ID: G105377536

LINC02174

Other Name(s): long intergenic non-protein coding RNA 2174 | Long intergenic non-protein coding RNA 2174

LINC02174: A Long Intergenic Non-Protein-Coding RNA

Non-Protein-Coding RNAs (NP-CsRNAs) have emerged as a promising candidate for drug targets and biomarkers due to their diverse functions in various cellular processes. Among them, Long Intergenic Non-Protein-Coding RNAs (LINC02174) have garnered significant attention due to their unique properties and potential involvement in various biological processes. In this article, we will explore LINC02174, its functions, potential drug targets, and potential as a biomarker.

Molecular Characterization

LINC02174 was identified as a novel NP-CsRNA using transcriptomics experiments. It has a length of approximately 2174 nucleotides and is located between the intron-exon boundaries of exons 1 and 2 of the human gene ZNF2 (encoding the transcription factor Zinc Finger Nucleotide-Binding Protein 2). ZNF2 is a key regulator of stem cell proliferation and is involved in various cellular processes, including cell growth, differentiation, and survival.

Function and Potential Drug Targets

LINC02174 is involved in various cellular processes, including cell growth, differentiation, and survival. It has been shown to be highly expressed in various tissues and cells, including stem cells, tissues, and organs. Additionally, LINC02174 has been shown to play a role in the regulation of cellular processes such as cell cycle progression, apoptosis, and inflammation.

Due to its involvement in various cellular processes, LINC02174 is a potential drug target. various methods, including RNA interference, microarray analysis, and biochemical assays have been used to identify potential drug targets for LINC02174. One of the most promising targets is the protein p53, which is a well-known tumor suppressor protein that plays a crucial role in regulating cell growth and apoptosis.

The p53 gene has been known to be regulated by various factors, including LINC02174. Several studies have shown that LINC02174 can interact with the p53 protein and enhance its activity. This interaction between LINC02174 and p53 suggests that LINC02174 may be a useful drug target for the treatment of various diseases, including cancer.

Another potential drug target for LINC02174 is the gene responsible for the production of reactive oxygen species (ROS), which can cause oxidative stress and contribute to various diseases, including cancer and neurodegenerative diseases. LINC02174 has been shown to be involved in the regulation of ROS production and has been shown to play a role in the detoxification of ROS.

Potential as a Biomarker

The identification of LINC02174 as a novel NP-CsRNA has also led to its potential as a biomarker. due to its unique properties and involvement in various cellular processes, LINC02174 has the potential to serve as a biomarker for various diseases, including cancer, neurodegenerative diseases, and aging.

One of the most promising applications of LINC02174 as a biomarker is its potential to serve as a diagnostic marker for cancer. LINC02174 has been shown to be highly expressed in various types of cancer, including breast, lung, and ovarian cancer. Additionally, studies have shown that LINC02174 can be used as a biomarker for monitoring the effectiveness of various cancer treatments.

Another application of LINC02174 as a biomarker is its potential to serve as a tool for studying the aging process. LINC02174 has been shown to be involved in various cellular processes that are associated with aging, including the regulation of stem cell proliferation and the production of reactive oxygen species.

Conclusion

In conclusion, LINC02174 is a novel Long Intergenic Non-Protein-Coding RNA that has been identified through transcriptomics experiments. It has been shown to be involved in various cellular processes, including cell growth, differentiation, and survival, and has the potential to serve as a drug target and a biomarker for various diseases, including cancer and neurodegenerative diseases. Further research is needed to fully understand the functions of LINC02174 and its potential as a drug and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 2174

The "LINC02174 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02174 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets